Breathlessness
34
3
5
18
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.9%
2 terminated out of 34 trials
90.0%
+3.4% vs benchmark
3%
1 trials in Phase 3/4
6%
1 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 18 completed trials
Clinical Trials (34)
Reducing Breathlessness With Dronabinol in COPD Patients
Mindfulness-Oriented Respiratory Distress Symptom Intervention for Lung Cancer
Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts
A Study to Evaluate the Effects of a Supplement on Mucus Clearance and Respiratory Symptoms
Management of Dyspnea With High- Flow Nasal Therapy
Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness
The Physiotherapy Assessment of Breathing Pattern Disorder
Multicomponent Breathlessness and Physical Activity Intervention in People With Asthma Using a Digital Platform
"Breathlessness Diagnostics in a Box" (BiaB) for Primary Care. A Multi-country Quality Improvement Project Using a Randomized Stepped-wedge Design
Management of Breathlessness with High-flow Nasal Therapy or a Fan
Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline
Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis
Connecting Breath and Mind for CYP With Long COVID
Participatory Action Research to Evaluate the Delivery of the MISSION ABC Service Model and Assess Health Service and Clinical Outcomes
Biomarker for Cystic Fibrosis
Long COVID and Post-exertional Pulmonary Diffusion
Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers
The Relating Experienced To Recalled Breathlessness Observational Study
Melodica Orchestra for Dyspnea: Safety and Feasibility Pilot
Breathibg Exercises and Inhaler Trainingfor Chronic Obstructive Pulmonary Disease (COPD) Patients